HISTOGENICS CORPORATION
830 WINTER STREET, 3RD FLOOR
WALTHAM, MA 02451
November 28, 2014
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Attention: | Amanda Ravitz | |
Jay Mumford | ||
David Morris |
Re: | Histogenics Corporation |
Registration Statement on Form S-1 (File No. 333-199202)
Request for Acceleration of Effective Date
Dear Ms. Ravitz and Mr. Mumford:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Histogenics Corporation (the Registrant) hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-199202) (as amended, the Registration Statement), so that it may become effective at 5:00 p.m. Eastern Time on December 2, 2014, or as soon thereafter as practicable. By separate letter, the representatives of the underwriters of the issuance of the securities being registered join this request for acceleration.
The Registrant hereby acknowledges that:
(i) should the Securities and Exchange Commission (the Commission) or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;
(ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and
(iii) the Registrant may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
[Signature Page Follows]
1
Please do not hesitate to contact our legal counsel, Albert Vanderlaan at (617) 648-9298 if you have any questions or would like additional information regarding this matter.
Sincerely, | ||
Histogenics Corporation | ||
By: | /s/ Adam Gridley | |
Adam Gridley | ||
President and Chief Executive Officer |
cc: | Albert Vanderlaan, Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP |
2